GE HealthCare Technologies Inc. GEHC revenue by segment, product and geography
In its fiscal year ending 2025-12-31, GE HealthCare Technologies Inc. reported revenue across 2 products and services; the largest, Product, was $13.7B, 66.2% of the filed sum (+4.5% against the prior period in the same filing).
Reported segment mix
figures as filed · share of the filed sum · change vs the prior period in the same filing- Product$13.7B66.2%+4.5% yoy
- Service$6.96B33.8%+5.6% yoy
Members sum to the consolidated $20.6B for this period.
- Other countries$9.43B45.7%+5.7% yoy
- United States$9.17B44.4%+6.4% yoy
- China$2.03B9.8%-4.9% yoy
Members sum to the consolidated $20.6B for this period.
- Product$3.42B64.5%+4.7% yoy
- Service$1.88B35.5%+7.7% yoy
Change is against the same quarter a year earlier, as reported in the same 10-Q.
Source: SEC DERA Financial Statement and Notes data sets. Dimensional XBRL facts on the business-segment, product/service and geographic axes; the engine keeps the accession of every figure. Descriptive and educational, not advice.
About these figures
Companies tag segment, product and geographic revenue as dimensional XBRL facts in their 10-K and 10-Q filings. The SEC publishes those facts in its DERA Financial Statement and Notes data sets; TrendNalysis ingests each monthly file and serves the facts exactly as filed, keyed to the accession of the filing. Shares are of the filed sum. Where a filer tags more than one breakdown on one axis, the sum exceeds consolidated revenue and no shares are computed; where the members do not add up to the consolidated figure, the residual is stated rather than hidden. Missing is never zero.
Descriptive and educational; not investment advice. Methodology and data lineage.